Clinical Trial Update: r-hLIF for Improving Embryo Implantation in IVF [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial update of recombinant human leukemia inhibitory factor (r-hLIF) to improve embryo implantation in IVF, sponsored by Merck KGaA, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• r-hLIF (recombinant human leukemia inhibitory factor)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility Implantation Failure | Phase 1, Phase 2 | Status: COMPLETED